UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$488M |
| 2 |
NXP Semiconductors
NXPI
|
+$484M |
| 3 |
JPMorgan Chase
JPM
|
+$429M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$426M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$755M |
| 2 |
Apple
AAPL
|
+$563M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$419M |
| 4 |
PepsiCo
PEP
|
+$387M |
| 5 |
Meta Platforms (Facebook)
META
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.14% |
| 2 | Financials | 7.54% |
| 3 | Healthcare | 5.64% |
| 4 | Industrials | 5.09% |
| 5 | Consumer Discretionary | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Melco Resorts & Entertainment
MLCO
$2.14B
| $6.74M | ﹤0.01% |
232,399
-54,448
| -19% | -$1.53M |
|
|
BDN
2027
Brandywine Realty Trust
BDN
$560M
| $6.73M | ﹤0.01% |
423,642
-550,542
| -57% | -$9.16M |
|
2028
Bio-Rad Laboratories Class A
BIO
$9.12B
| $6.72M | ﹤0.01% |
26,883
-345
| -1% | -$87.8K |
|
2029
Thor Industries
THO
$4.08B
| $6.71M | ﹤0.01% |
58,255
-27,473
| -32% | -$3.67M |
|
2030
Invesco DB US Dollar Index Bullish Fund
UUP
$424M
| $6.7M | ﹤0.01% |
283,534
-12,994
| -4% | -$306K |
|
|
AVXS
2031
DELISTED
AveXis, Inc. Common Stock
AVXS
| $6.69M | ﹤0.01% |
54,168
+36,540
| +207% | +$4.34M |
|
|
UMPQ
2032
DELISTED
Umpqua Holdings Corp
UMPQ
| $6.69M | ﹤0.01% |
312,500
+41,712
| +15% | +$911K |
|
2033
Snap-on
SNA
$21.4B
| $6.68M | ﹤0.01% |
45,300
-17,335
| -28% | -$2.85M |
|
2034
OR Royalties Inc
OR
$6.02B
| $6.68M | ﹤0.01% |
690,688
+32,795
| +5% | +$346K |
|
|
SFBS
2035
ServisFirst Bancshares
SFBS
$4.88B
| $6.67M | ﹤0.01% |
163,533
+1,154
| +0.7% | +$48.4K |
|
|
DCP
2036
PUT
DELISTED
DCP Midstream, LP
DCP
| $6.67M | ﹤0.01% |
+190,000
| New | +$7.23M |
|
|
NFX
2037
DELISTED
Newfield Exploration
NFX
| $6.66M | ﹤0.01% |
272,620
+89,195
| +49% | +$2.5M |
|
2038
State Street SPDR Portfolio TIPS ETF
SPIP
$999M
| $6.64M | ﹤0.01% |
238,272
+38,680
| +19% | +$1.07M |
|
2039
Pacer Global Cash Cows Dividend ETF
GCOW
$3.45B
| $6.63M | ﹤0.01% |
217,255
+64,233
| +42% | +$2.03M |
|
2040
ITT
ITT
$19.2B
| $6.63M | ﹤0.01% |
135,338
+79,935
| +144% | +$4.22M |
|
2041
CALL
Invesco CurrencyShares Euro Currency Trust
FXE
$340M
| $6.63M | ﹤0.01% |
56,000
-131,300
| -70% | -$15.5M |
|
|
CVRR
2042
DELISTED
CVR Refining, LP
CVRR
| $6.62M | ﹤0.01% |
507,568
-340,742
| -40% | -$5.05M |
|
|
BBRC
2043
DELISTED
Columbia Beyond BRICs ETF
BBRC
| $6.62M | ﹤0.01% |
339,626
+11,545
| +4% | +$226K |
|
2044
WisdomTree US Total Dividend Fund
DTD
$1.68B
| $6.62M | ﹤0.01% |
148,566
+1,496
| +1% | +$69.2K |
|
|
JPXN
2045
iShares JPX-Nikkei 400 ETF
JPXN
$138M
| $6.61M | ﹤0.01% |
100,383
+53,931
| +116% | +$3.59M |
|
|
JTD
2046
DELISTED
NUVEEN TAX-ADVANTAGE DIVIDEND GROWTH FUND
JTD
| $6.61M | ﹤0.01% |
403,649
-12,079
| -3% | -$210K |
|
2047
Vanguard Long-Term Treasury ETF
VGLT
$10.1B
| $6.6M | ﹤0.01% |
87,962
-7,666
| -8% | -$570K |
|
2048
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.2B
| $6.59M | ﹤0.01% |
527,128
+43,899
| +9% | +$574K |
|
|
GBT
2049
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $6.59M | ﹤0.01% |
136,394
+102,351
| +301% | +$5.71M |
|
|
VISN
2050
Vistance Networks Inc
VISN
$2.31B
| $6.58M | ﹤0.01% |
164,547
+50,840
| +45% | +$1.98M |
|
Similar funds
UBS Group's Q1 2018 Portfolio in Review
As of Q1 2018, UBS Group held 8,641 positions worth $232B, down 4.8% from $243B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $8.61B in Q1 2018, closing 751 positions and reducing 3,579 holdings. Its most notable exit was CalAtlantic Group, Inc., an estimated $60.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.2% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Nutrien worth $56.3M.
- UBS Group's largest Q1 2018 buy was Nutrien: 1,191,668 shares worth $56.3M.
- UBS Group added most to Comcast in Q1 2018, an estimated $488M increase.
- UBS Group's biggest Q1 2018 reduction was UBS Group, cutting an estimated $755M.
- UBS Group fully exited CalAtlantic Group, Inc. in Q1 2018, selling an estimated $60.8M.
- UBS Group's ten largest holdings make up 15% of its $232B portfolio in Q1 2018.
- UBS Group opened 725 new positions and closed 751 in Q1 2018.
- UBS Group's portfolio value fell 4.8% quarter-over-quarter to $232B.
Based on UBS Group's 13F filing for Q1 2018, filed 15 May 2018.